🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: \- To assess the pharmacokinetic (PK) and pharmacodynam...
Status
Terminated
Location
Investigational Site Number 348001
Start Date
2012-05
Trial ID
NCT01567904
Treatments Being Tested
The primary objective is to evaluate the efficacy of once daily (QD) subcut...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2008-06
Trial ID
NCT00709904
Treatments Being Tested
The primary objective was to compare the efficacy of once daily \[q.d\] sub...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2008-07
Trial ID
NCT00721760
Treatments Being Tested
The primary objective was to demonstrate the dose-response of Semuloparin s...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2006-05
Trial ID
NCT00331838
The primary objective was to compare the efficacy of once daily \[q.d\] sub...
Status
Terminated
Location
Sanofi-Aventis Administrative Office
Start Date
2008-07
Trial ID
NCT00714597
Treatments Being Tested
The primary objective was to compare the efficacy of Semuloparin sodium (AV...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2008-07
Trial ID
NCT00718224
Treatments Being Tested
The primary objective was to compare the efficacy of once daily \[q.d.\] su...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2008-06
Trial ID
NCT00697099
Treatments Being Tested
The primary objective was to compare the efficacy of once daily subcutaneou...
Status
Completed
Location
Investigational Site Number 840006
Start Date
2008-06
Trial ID
NCT00694382
Treatments Being Tested
The primary objective is to compare the efficacy and safety of once daily (...
Status
Completed
Location
Investigational Site Number 840026
Start Date
2008-04
Trial ID
NCT00679588
Treatments Being Tested